Novo Nordisk missed its diversity targets last year, and its CEO paid a financial price

[
Novo Nordisk’s CEO took a $1.5 million pay cut in 2024 as the pharma giant’s share price tanked and it missed profit and DEI targets. Read More
https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-2174206073-e1738766467341.jpg?resize=1200,600
https://fortune.com/europe/2025/02/05/novo-nordisk-missed-dei-targets-last-year-ceo-paid-financial-price/


Ryan Hogg